PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Environ Res. Author manuscript; available in PMC 2010 October 1.
Published in final edited form as:
PMCID: PMC2743774
NIHMSID: NIHMS126670

Multiple Metals Predict Prolactin and Thyrotropin (TSH) Levels in Men

Abstract

Exposure to a number of metals can affect neuroendocrine and thyroid signaling, which can result in adverse effects on development, behavior, metabolism, reproduction, and other functions. The present study assessed the relationship between metal concentrations in blood and serum prolactin (PRL) and thyrotropin (TSH) levels, markers of dopaminergic and thyroid function, respectively, among men participating in a study of environmental influences on male reproductive health. Blood samples from 219 men were analyzed for concentrations of 11 metals and serum levels of PRL and TSH. In multiple linear regression models adjusted for age, BMI and smoking, PRL was inversely associated with arsenic, cadmium, copper, lead, manganese, molybdenum, and zinc, but positively associated with chromium. Several of these associations (Cd, Pb, Mo) are consistent with limited studies in humans or animals, and a number of the relationships (Cr, Cu, Pb, Mo) remained when additionally considering multiple metals in the model. Lead and copper were associated with non-monotonic decreases in TSH, while arsenic was associated with a dose-dependent increase in TSH. For arsenic these findings were consistent with recent experimental studies where arsenic inhibited enzymes involved in thyroid hormone synthesis and signaling. More research is needed for a better understanding of the role of metals in neuroendocrine and thyroid function and related health implications.

Keywords: endocrine, exposure, epidemiology, human, male

INTRODUCTION

A number of metals can accumulate in the brain (Popek et al. 2006; Hu 2000) and affect neuroendocrine function, including adverse impacts on the dopaminergic system and related behavioral abnormalities (Jones and Miller 2008). Dopamine, along with other factors (including thyrotropin releasing hormone (TRH)), regulate the release of prolactin (PRL). PRL is a protein hormone that serves a number of vital functions involving metabolism, reproduction, and maintenance of homeostasis in immune responses, osmotic balance and angiogenesis (Ben-Jonathan et al. 2008; Freeman et al. 2000), and is becoming increasingly used as a measure of neuroendocrine/dopaminergic function in environmental and occupational epidemiology studies. For example, environmental levels of cadmium and mercury were inversely associated with PRL levels in children (de Burbre et al. 2006). Lead was inversely associated with PRL among men (Telisman et al. 2007) and pregnant women (Takser et al. 2005) without occupational lead exposure, but positively associated with PRL among occupationally exposed men (Lucchini et al. 2000; Govoni et al. 1987). Occupational exposure to manganese has also been positively associated with PRL (Ellingsen et al. 2007; 2003), as has environmental manganese exposure among adults (Montes et al. 2008) and neonates (Takser et al. 2004).

In addition to regulating PRL, dopamine is also involved in thyrotropin (TSH) activity and TSH subunit secretion (Soldin and Aschner 2007), though TSH is primarily controlled by TRH. TSH stimulates secretion of thyroid hormones, which are vital to a number of physiological processes including metabolism, reproduction, and neurodevelopment. There is limited evidence that a number of metals may affect thyroid function, including inorganic arsenic (Davey et al. 2008), cadmium (Iijima et al. 2007), lead (Dundar et al. 2006), manganese (Soldin and Aschner 2007) and organic mercury (Soldin et al. 2008), as well as copper, selenium and zinc (Arthur and Beckett 1999). Alterations in circulating thyroid hormone or TSH levels in relation to exposure may be due to effects at different levels of the hypothalamus-pituitary-thyroid axis, and/or may be a result of altered thyroid hormone transport and peripheral metabolism/deactivation (Zoeller et al. 2007; Boas et al. 2006). In the present study we assessed blood metal concentrations and serum PRL and TSH levels among men participating in a larger study of environmental factors in male reproduction.

METHODS

Subject Recruitment

The study cohort has been described in a previous report (Wirth et al. 2007). Briefly, men aged 18 to 55 were recruited from two Michigan infertility clinics. Men taking hormone therapy or who had diabetes, thyroid or adrenal disorders, or other medical conditions associated with infertility were not eligible for enrollment. Since couples may present at the clinics for problems relating to male and/or female fertility problems, participants included fertile men and men with a range of fertility problems. The protocols of the study were approved by the committees on research ethics at all participating institutions.

Hormone Measurement

Blood samples were collected from participants during a morning clinic visit. PRL and TSH were measured by solid phase, two site, chemiluminescent enzyme immunometric assay using the Immulite Assay System (Diagnostic Products Corp., Los Angeles, CA). The intra- and inter-assay variabilities, expressed as coefficient of variations, were 6.2 and 8.5 for PRL and 7.1 and 11.1 for TSH. Assay sensitivities were 0.5 ng/mL for PRL and 0.004 µIU/mL for TSH.

Measurement of Metals

Whole venous blood was collected using stainless steel needles into 2 mL plastic tubes containing EDTA (prescreened for mercury, cadmium and lead). Samples were analyzed for arsenic (As), cadmium (Cd), chromium (Cr), copper (Cu), lead (Pb), manganese (Mn), total mercury (Hg), molybdenum (Mo), selenium (Se), thallium (Tl) and zinc (Zn) using a Perkin Elmer Elan DRC plus Inductively Coupled Plasma Mass Spectrometer (ICP-MS). The limits of detection (LOD) for the blood metal levels were as follows: As, 4.0 µg/L; Cd, 0.2 µg/L; Cu, 2.0 µg/L; Cr, 0.5 µg/L; Pb, 0.3 µg/dL; Mn, 1.0 µg/L; Hg, 0.2 µg/L; Mo, 1.0 µg/L; Se, 5 µg/L; Tl, 0.1 µg/L; and Zn, 50 µg/L.

Statistical Analysis

Data analysis was performed using SAS version 9.1 (SAS Institute Inc., Cary, NC, USA). Due to the high proportion of samples below the LOD for a number of the metals, these variables were categorized into groups. At least 3 groups were formed for each metal to investigate dose-dependent relationships. Metals with greater then 75% of samples greater than the LOD were categorized into quartiles. For the other metals grouping cutpoints were determined by the percentage of samples above the LOD. The low group consisted of values below the LOD for each metal, while the medium and high groups were made up of equal-sized bins among the detected values. The association between metal exposure categories and PRL or TSH levels were assessed by multiple linear regression in separate models for each metal. PRL and TSH levels were skewed right and transformed by the natural logarithm in the data analysis. Full linear regression models were then constructed when considering all metals along with the other covariates (age, BMI, race, income, season and smoking status). The backward elimination procedure was utilized and alpha was set at 0.1 for variables to be retained in the model. Covariates not retained in the final model were then added individually to further explore evidence of confounding (i.e. causing >10% change in metal effect estimate). Finally, evidence of interaction between metals in the association with hormone levels was explored by comparing effect estimates of one metal while stratifying by blood levels of another metal.

RESULTS

Among the 219 men who contributed data on both hormone and metal concentrations, the median (25th, 75th) PRL and TSH values were 9.8 ng/mL (7.4, 12.4) and 1.32 µIU/mL (0.96, 1.83), respectively. The distributions of blood metal concentrations among these men were representative of low-level environmental exposures and have been previously reported (Meeker et al. 2008). Cutoff values for exposure categories used in the data analysis are presented in Table 1, along with linear regression results for each metal separately in crude analyses and when adjusted for age, BMI and smoking status. In the adjusted analysis chromium was positively associated with PRL, while arsenic, cadmium, copper, lead, manganese, molybdenum and zinc were all inversely associated with PRL. Copper and lead were associated with non-monotonic declines in TSH, whereas arsenic and thallium were suggestively associated with increased TSH.

Table 1
Crude and adjusteda regression coefficients for change in serum hormone level associated with metal exposure groups.

Table 2 presents the results from the multivariable analysis that considered all measured metals simultaneously. PRL remained positively associated with chromium and inversely associated with copper, lead, and molybdenum, as well as with age, race and smoking. The inverse associations for lead and molybdenum followed a dose-dependent pattern. Cadmium, manganese, and zinc, which were inversely related to PRL in the multivariable models for individual metals, were not retained in the final model. In the full TSH model arsenic was associated with a monotonic increase in TSH, and copper and lead were associated with non-monotonic decreases in TSH. Finally, in secondary analyses there was no evidence for interactions between metals in the associations with PRL or TSH. Results were also similar to those presented in Table 1 and Table 2 when excluding smokers from the analyses.

Table 2
Final linear regression modelsa for hormone levels when considering multiple metals and other covariates.

DISCUSSION

We found that multiple metals were associated with PRL and TSH levels in men, but the direction of the association was not consistent among metals which may potentially suggest differing sites and mechanisms of action that manifest as altered PRL or TSH levels. Because multiple comparisons were made, some of the associations may be due to chance. In addition, there may have been unmeasured co-exposures that may have confounded our findings (e.g. simultaneous exposure to arsenic and iodine from seafood consumption). However, a number of our findings are consistent with previous human, animal, or in vitro studies.

Our finding of an inverse association between lead and PRL is consistent with a recent study among 240 Croatian men with no occupational exposure to metals, though exposure levels in that study were somewhat higher than those in the present study (Telisman et al. 2007). Likewise, an inverse relationship between lead and PRL was reported among pregnant women in Canada (Takser et al. 2005). de Burbure et al. (2006) also reported an inverse association between lead and PRL in children, but only as an interaction with cadmium. In addition to lead, the present study also found an inverse relationship between copper and PRL. This is inconsistent with previous studies among men in Croatia that did not report an association between copper and PRL (Telisman et al. 2007; Jurasovic et al. 2004; Telisman et al. 2000). To our knowledge this is the first human study to assess PRL in relation to molybdenum and chromium, where PRL was inversely associated with molybdenum and positively associated with chromium. These findings are consistent with a rat study that reported an inverse association between molybdenum and PRL (Bandyopadhyay et al. 1981), but inconsistent with a recent study that reported hexavalent chromium caused adverse effects on the hypothalamus and anterior pituitary and resulted in reduced serum PRL levels in rats (Quinteros et al. 2007). However, we measured only total chromium. The proportion of exposure to chromium in the hexavalent form in these men may be expected to be low and/or quickly reduced to trivalent chromium upon uptake.

Although cadmium was not retained in the final PRL model that considered other metals, our finding of an inverse association between cadmium and PRL in the initial multivariable model was consistent with previous human studies among Croatian men with potential occupational exposure (Telisman et al. 2000), among Croatian men with no specific occupational exposure to metals (Jurasovic et al. 2004), and among children (de Burbure et al. 2006). Conversely, manganese, which was also inversely associated with PRL in our initial multivariable model prior to consideration of other metals, was positively associated with PRL in human studies of neonates (Takser et al. 2004), adults (Montes et al. 2008), and occupationally exposed men (Ellingsen et al. 2007; 2003).

TSH was positively associated with arsenic in the present study, which is consistent with experimental data demonstrating that arsenic trioxide inhibits thyroid peroxidase activity (TPO) in vitro (Palazzolo and Jansen 2008). TPO is the major enzyme involved in thyroid hormone synthesis, and TPO inhibition likely results in declined thyroid hormone levels, which, through feedback mechanisms, would result in increased TSH. Another recent study reported that low doses of arsenic disrupted thyroid hormone receptor-mediated gene regulation and amphibian developmental processes that are mediated by thyroid hormones (Davey et al. 2008). Finally, we found non-monotonic inverse relationships between TSH and copper and lead. Human studies of copper and thyroid function are lacking and those for lead have been inconsistent (Dundar et al. 2006), though our findings of declined TSH in relation to lead are consistent with findings among women (but not men) in a recent study (Abdelouahab et al. 2008) and may be indicative of altered pituitary function (Gustafson et al. 1989).

In conclusion, we found that a number of metals were associated with PRL and TSH levels in men. More research, including human studies with more detailed markers of dopaminergic and thyroid function, is needed to further explain the potential influence of metals on these systems.

Acknowledgments

This work was supported by grant ES11856 from the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). JDM supported by a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Human Subjects: All participants gave informed consent. Consent forms and protocols of the study were approved by the committees on research ethics at all participating institutions.

REFERENCES

  • Abdelouahab N, Mergler D, Takser L, Vanier C, St-Jean M, Baldwin M, Spear PA, Chan HM. Gender differences in the effects of organochlorines, mercury, and lead on thyroid hormone levels in lakeside communities of Quebec (Canada) Environ Res. 2008;107:380–392. [PubMed]
  • Arthur JR, Beckett GJ. Thyroid function. Br Med Bull. 1999;55:658–668. [PubMed]
  • Bandyopadhyay SK, Chatterjee K, Tiwari RK, Mitra A, Banerjee A, Ghosh KK, Chatterjee GC. Biochemical studies on molybdenum toxicity in rats: effects of high protein feeding. Int J Vitam Nutr Res. 1981;51:401–409. [PubMed]
  • Ben-Jonathan N, LaPensee CR, LaPensee EW. What can we learn from rodents about prolactin in humans? Endocr Rev. 2008;29:1–41. [PubMed]
  • Boas M, Feldt-Rasmussen U, Skakkebaek NE, Main KM. Environmental chemicals and thyroid function. Eur J Endocrinol. 2006;154:599–611. [PubMed]
  • Davey JC, Nomikos AP, Wungjiranirun M, Sherman JR, Ingram L, Batki C, Lariviere JP, Hamilton JW. Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor-and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis. Environ Health Perspect. 2008;116:165–712. [PMC free article] [PubMed]
  • de Burbure C, Buchet JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A, Smerhovsky Z, Cikrt M, Trzcinka-Ochocka M, Razniewska G, Jakubowski M, Bernard A. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect. 2006;114:584–590. [PMC free article] [PubMed]
  • Dundar B, Oktem F, Arslan MK, Delibas N, Baykal B, Arslan C, Gultepe M, Ilhan IE. The effect of long-term low-dose lead exposure on thyroid function in adolescents. Environ Res. 2006;101:140–145. [PubMed]
  • Ellingsen DG, Chashchin V, Haug E, Chashchin M, Tkachenko V, Lubnina N, Bast-Pettersen R, Thomassen Y. An epidemiological study of reproductive function biomarkers in male welders. Biomarkers. 2007;12:497–509. [PubMed]
  • Ellingsen DG, Haug E, Gaarder PI, Bast-Pettersen R, Thomassen Y. Endocrine and immunologic markers in manganese alloy production workers. Scand J Work Environ Health. 2003;29:230–238. [PubMed]
  • Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80:1523–1631. [PubMed]
  • Govoni S, Battaini F, Fernicola C, Castelletti L, Trabucchi M. Plasma prolactin concentrations in lead exposed workers. J Environ Pathol Toxicol Oncol. 1987;7:13–15. [PubMed]
  • Gustafson A, Hedner P, Schutz A, Skerfving S. Occupational lead exposure and pituitary function. Int Arch Occup Environ Health. 1989;61:277–281. [PubMed]
  • Hu H. Exposure to metals. Prim Care. 2000;27:983–996. [PubMed]
  • Iijima K, Otake T, Yoshinaga J, Ikegami M, Suzuki E, Naruse H, Yamanaka T, Shibuya N, Yasumizu T, Kato N. Cadmium, lead, and selenium in cord blood and thyroid hormone status of newborns. Biol Trace Elem Res. 2007;119:10–18. [PubMed]
  • Jones DC, Miller GW. The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochem Pharmacol. 2008;76:569–581. [PubMed]
  • Jurasovic J, Cvitkovic P, Pizent A, Colak B, Telisman S. Semen quality and reproductive endocrine function with regard to blood cadmium in Croatian male subjects. Biometals. 2004;17:735–743. [PubMed]
  • Lucchini R, Albini E, Cortesi I, Placidi D, Bergamaschi E, Traversa F, Alessio L. Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure. Neurotoxicology. 2000;21:805–811. [PubMed]
  • Meeker JD, Rossano MG, Protas B, Diamond MP, Puscheck E, Daly D, Paneth N, Wirth JJ. Cadmium, lead, and other metals in relation to semen quality: human evidence for molybdenum as a male reproductive toxicant. Environ Health Perspect. 2008;116:1473–1479. [PMC free article] [PubMed]
  • Montes S, Riojas-Rodriguez H, Sabido-Pedraza E, Rios C. Biomarkers of manganese exposure in a population living close to a mine and mineral processing plant in Mexico. Environ Res. 2008;106:89–95. [PubMed]
  • Palazzolo DL, Jansen KP. The minimal arsenic concentration required to inhibit the activity of thyroid peroxidase activity in vitro. Biol Trace Elem Res. 2008;126:49–55. [PubMed]
  • Popek W, Dietrich G, Glogowski J, Demska-Zakes K, Drag-Kozak E, Sionkowski J, Luszczek-Trojan E, Epler P, Demianowicz W, Sarosiek B, Kowalski R, Jankun M, Zakes Z, Krol J, Czerniak S, Szczepkowski M. Influence of heavy metals and 4-nonylphenol on reproductive function in fish. Reprod Biol. 2006;6 Suppl 1:175–188. [PubMed]
  • Quinteros FA, Poliandri AH, Machiavelli LI, Cabilla JP, Duvilanski BH. In vivo and in vitro effects of chromium VI on anterior pituitary hormone release and cell viability. Toxicol Appl Pharmacol. 2007;218:79–87. [PubMed]
  • Soldin OP, O'Mara DM, Aschner M. Thyroid Hormones and Methylmercury Toxicity. Biol Trace Elem Res. 2008 [PMC free article] [PubMed]
  • Soldin OP, Aschner M. Effects of manganese on thyroid hormone homeostasis: potential links. Neurotoxicology. 2007;28:951–956. [PMC free article] [PubMed]
  • Takser L, Mergler D, Lafond J. Very low level environmental exposure to lead and prolactin levels during pregnancy. Neurotoxicol Teratol. 2005;27:505–508. [PubMed]
  • Takser L, Mergler D, de Grosbois S, Smargiassi A, Lafond J. Blood manganese content at birth and cord serum prolactin levels. Neurotoxicol Teratol. 2004;26:811–815. [PubMed]
  • Telisman S, Colak B, Pizent A, Jurasovic J, Cvitkovic P. Reproductive toxicity of low-level lead exposure in men. Environ Res. 2007;105:256–266. [PubMed]
  • Telisman S, Cvitkovic P, Jurasovic J, Pizent A, Gavella M, Rocic B. Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. Environ Health Perspect. 2000;108:45–53. [PMC free article] [PubMed]
  • Wirth JJ, Rossano MG, Daly DC, Paneth N, Puscheck E, Potter RC, Diamond MP. Ambient manganese exposure is negatively associated with human sperm motility and concentration. Epidemiology. 2007;18:270–273. [PubMed]
  • Zoeller RT, Tan SW, Tyl RW. General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol. 2007;37:11–53. [PubMed]